论文部分内容阅读
目的:探究阿奇霉素治疗小儿肺炎的疗效与安全性,为今后的临床工作提供参考依据。方法:将我社区中心2012年3月~2013年3月收治的80例小儿肺炎患者纳入本次研究,按照治疗方式的不同分为对照组与观察组,对照组给予红霉素治疗,观察组给予阿奇霉素治疗,观察两组患儿治疗后的效果、临床症状改善时间及不良反应。结果:观察组治疗效果、症状改善时间均优于对照组,而不良反应明显少于对照组(P<0.05),差异具有统计学意义。结论:阿奇霉素治疗小儿肺炎效果确切,能迅速缓解患儿的临床症状,同时无严重不良反应,是一种价值较高的治疗药物,可在临床进行借鉴推广。
Objective: To investigate the efficacy and safety of azithromycin in the treatment of pediatric pneumonia, and to provide a reference for future clinical work. Methods: 80 cases of pediatric pneumonia admitted to our community center from March 2012 to March 2013 were included in this study. The patients were divided into control group and observation group according to different treatment methods. The control group was treated with erythromycin, and the observation group Give azithromycin treatment, observe the effect of two groups of children after treatment, improvement of clinical symptoms and adverse reactions. Results: The treatment effect and symptom improvement time in the observation group were better than those in the control group, while the adverse reactions were significantly less than those in the control group (P <0.05). The difference was statistically significant. Conclusion: Azithromycin is effective in treating children with pneumonia and can quickly relieve the clinical symptoms of children without serious adverse reactions. It is a valuable therapeutic drug and can be used for reference in clinic.